INR 57.44
(2.85%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | 82.9 Million INR | 14.49% |
2022 | 72.41 Million INR | 50.49% |
2021 | 48.12 Million INR | 85.79% |
2020 | 25.9 Million INR | 58.86% |
2019 | 16.3 Million INR | 3.84% |
2018 | 15.7 Million INR | 28.68% |
2017 | 12.2 Million INR | -25.06% |
2016 | 16.28 Million INR | 44.1% |
2015 | 11.29 Million INR | 42.66% |
2014 | 7.92 Million INR | 25.93% |
2013 | 6.28 Million INR | 47.11% |
2012 | 4.27 Million INR | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | 15.78 Million INR | -49.05% |
2023 Q3 | 14.45 Million INR | -40.43% |
2023 Q4 | 30.99 Million INR | 114.41% |
2023 FY | 82.9 Million INR | 14.49% |
2023 Q1 | 13.2 Million INR | -25.24% |
2023 Q2 | 24.26 Million INR | 83.78% |
2022 Q4 | 17.65 Million INR | -21.5% |
2022 Q3 | 22.49 Million INR | -21.57% |
2022 Q2 | 28.68 Million INR | 701.17% |
2022 Q1 | 3.58 Million INR | -82.44% |
2022 FY | 72.41 Million INR | 50.49% |
2021 Q4 | 20.39 Million INR | 100.94% |
2021 Q1 | 1.41 Million INR | -70.24% |
2021 Q2 | 16.75 Million INR | 1081.45% |
2021 Q3 | 10.14 Million INR | -39.43% |
2021 FY | 48.12 Million INR | 85.79% |
2020 Q2 | 8.18 Million INR | 0.0% |
2020 Q4 | 4.76 Million INR | 0.0% |
2020 Q3 | 4.76 Million INR | -41.77% |
2020 Q1 | 8.18 Million INR | 97.52% |
2020 FY | 25.9 Million INR | 58.86% |
2019 Q3 | 4.14 Million INR | 3.39% |
2019 Q1 | 4 Million INR | -28.18% |
2019 FY | 16.3 Million INR | 3.84% |
2019 Q4 | 4.14 Million INR | 0.0% |
2019 Q2 | 4 Million INR | 0.0% |
2018 Q4 | 5.58 Million INR | 0.0% |
2018 FY | 15.7 Million INR | 28.68% |
2018 Q3 | 5.58 Million INR | 145.84% |
2018 Q1 | 2.27 Million INR | -44.63% |
2018 Q2 | 2.27 Million INR | 0.0% |
2017 FY | 12.2 Million INR | -25.06% |
2017 Q1 | 2 Million INR | 0.0% |
2017 Q2 | 2 Million INR | 0.0% |
2017 Q3 | 4.09 Million INR | 104.9% |
2017 Q4 | 4.09 Million INR | 0.0% |
2016 FY | 16.28 Million INR | 44.1% |
2015 FY | 11.29 Million INR | 42.66% |
2014 FY | 7.92 Million INR | 25.93% |
2013 FY | 6.28 Million INR | 47.11% |
2012 FY | 4.27 Million INR | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Alembic Pharmaceuticals Limited | 6.15 Billion INR | 98.654% |
Aurobindo Pharma Limited | 31.72 Billion INR | 99.739% |
Glenmark Life Sciences Limited | 4.7 Billion INR | 98.239% |
Granules India Limited | 4.05 Billion INR | 97.954% |
Indoco Remedies Limited | 984.6 Million INR | 91.579% |
Achyut Healthcare Limited | 5.73 Million INR | -1346.424% |
Ajanta Pharma Limited | 8.16 Billion INR | 98.984% |
Alkem Laboratories Limited | 17.95 Billion INR | 99.538% |
Alpa Laboratories Limited | 167.76 Million INR | 50.58% |
Brooks Laboratories Limited | -195.91 Million INR | 142.318% |
AstraZeneca Pharma India Limited | 1.61 Billion INR | 94.867% |
Bajaj HealthCare Limited | -837.93 Million INR | 109.894% |
Bliss GVS Pharma Limited | 754.54 Million INR | 89.012% |
Dr. Reddy's Laboratories Limited | 55.68 Billion INR | 99.851% |
Eris Lifesciences Limited | 3.91 Billion INR | 97.885% |
FDC Limited | 3.05 Billion INR | 97.284% |
Glenmark Pharmaceuticals Limited | -15.01 Billion INR | 100.552% |
Gufic Biosciences Limited | 861.35 Million INR | 90.375% |
Ind-Swift Laboratories Limited | 4.2 Billion INR | 98.03% |
Ipca Laboratories Limited | 5.47 Billion INR | 98.485% |
Jagsonpal Pharmaceuticals Limited | 224.63 Million INR | 63.091% |
Krebs Biochemicals & Industries Limited | -197.28 Million INR | 142.025% |
Lasa Supergenerics Limited | -217.3 Million INR | 138.153% |
Laurus Labs Limited | 1.6 Billion INR | 94.836% |
Lupin Limited | 19.14 Billion INR | 99.567% |
Mankind Pharma Limited | 19.12 Billion INR | 99.567% |
Medicamen Biotech Limited | 109.31 Million INR | 24.152% |
Megasoft Limited | -127.46 Million INR | 165.044% |
NATCO Pharma Limited | 13.88 Billion INR | 99.403% |
Piramal Pharma Limited | 178.2 Million INR | 53.474% |
RPG Life Sciences Limited | 876.6 Million INR | 90.542% |
Sigachi Industries Limited | 571.8 Million INR | 85.5% |
Sun Pharmaceutical Industries Limited | 95.76 Billion INR | 99.913% |
Suven Pharmaceuticals Limited | 3 Billion INR | 97.239% |
Syncom Formulations (India) Limited | 253.14 Million INR | 67.248% |
Unichem Laboratories Limited | -704.74 Million INR | 111.764% |
Wanbury Limited | 559.56 Million INR | 85.183% |
Windlas Biotech Limited | 581.87 Million INR | 85.751% |
ZIM Laboratories Limited | 172.46 Million INR | 51.927% |
Zydus Lifesciences Limited | 38.59 Billion INR | 99.785% |
Sun Pharma Advanced Research Company Limited | -3.87 Billion INR | 102.141% |
Divi's Laboratories Limited | 16 Billion INR | 99.482% |
Hester Biosciences Limited | 188.89 Million INR | 56.107% |
Procter & Gamble Health Limited | 2 Billion INR | 95.875% |
Amrutanjan Health Care Limited | 449.72 Million INR | 81.565% |
Bal Pharma Limited | 73.92 Million INR | -12.157% |
Strides Pharma Science Limited | -706.14 Million INR | 111.741% |
Venus Remedies Limited | 284.9 Million INR | 70.9% |
Aarti Pharmalabs Limited | 2.16 Billion INR | 96.178% |
Nectar Lifesciences Limited | 49.95 Million INR | -65.984% |
Shilpa Medicare Limited | 318.74 Million INR | 73.989% |
Aarti Drugs Limited | 1.71 Billion INR | 95.163% |
IOL Chemicals and Pharmaceuticals Limited | 1.34 Billion INR | 93.833% |
Suven Life Sciences Limited | -1.05 Billion INR | 107.89% |
Ind-Swift Limited | 142.31 Million INR | 41.742% |
Valiant Laboratories Limited | 3.19 Million INR | -2494.149% |
J. B. Chemicals & Pharmaceuticals Limited | 5.52 Billion INR | 98.5% |
Solara Active Pharma Sciences Limited | -5.67 Billion INR | 101.461% |
Themis Medicare Limited | 435.23 Million INR | 80.951% |
Hikal Limited | 696.02 Million INR | 88.088% |
Torrent Pharmaceuticals Limited | 16.56 Billion INR | 99.499% |
Sequent Scientific Limited | -358.69 Million INR | 123.114% |
Novartis India Limited | 851.9 Million INR | 90.268% |
Wockhardt Limited | -4.63 Billion INR | 101.791% |
Jubilant Pharmova Limited | 771 Million INR | 89.247% |
Biofil Chemicals and Pharmaceuticals Limited | 7.09 Million INR | -1069.05% |
Neuland Laboratories Limited | 3 Billion INR | 97.237% |
Morepen Laboratories Limited | 961.59 Million INR | 91.378% |
Kilitch Drugs (India) Limited | 146.01 Million INR | 43.218% |
Mangalam Drugs & Organics Limited | -90.71 Million INR | 191.393% |